Leprosy Mailing List – December 8, 2022
Ref.: (LML) Infolep monthly overview of new publications on leprosy, December 2022
From: Roos Geutjes, Marente Mol, Amsterdam, the Netherlands
Dear colleagues,
Last month, the 21st International Leprosy Congress took place in Hyderabad, India. The congress was a great success, with many interesting presentations, fruitful discussions and valuable connections, thereby strengthening international collaboration in working towards a world without leprosy. A big thanks to the organizing committee and all participants for their contribution!
Leprosy Research Initiative has announced two calls for proposals: a regular grant and a new research capacity strengthening grant. Researchers can now apply - make sure to submit your Letter of Intent timely!
More information on this, along with other news and events, can be found at the bottom of this newsletter.
The ILEP Technical Commission, Global Partnership for Zero Leprosy and Infolep collaborated to produce a fact-sheet on leprosy reactions. This document provides essential information on how to classify and manage reactions before, during, and after leprosy treatment.
Sunil Kumar Sahoo published a poetry book called 'The Felony', which illustrates the social injustice experienced by persons affected by leprosy. Thanks for sharing your work with us!
The links to the above mentioned publications can be found below. Enjoy reading these and other latest publications! Also, we would be happy to assist you with literature searches on Infolep.
Warm regards,
Roos Geutjes & Marente Mol
www.leprosy-information.org
info@infolep.org
Highlighted
Factsheet on Leprosy Reactions: Classify and manage reactions before, during, and after leprosy treatment
Global Partnership for Zero Leprosy, Infolep, ILEP Technical Commission. 2022.
THE FELONY (A story of social injustice since thousand years) (Poetry collection)
Sahoo SK. 2021.
Definition of symptoms guide for suspect case identification
Government of Telangana, National Leprosy Eradication Programme, NLEP LCDC, et al. 2022.
Inclusive Participation Toolbox
Christian Blind Mission (CBM). 2022.
Leprosy & COVID-19
Impact of COVID-19 on leprosy reactions and of leprosy treatments on COVID-19 severity
Ianhez M, Cerqueira SR, Gomes CM, et al. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2022.
Subdiagnóstico de Hanseníase no Brasil durante a Pandemia da Covid-19
Lopes JGCBS, da Silva IM, Leal MGC, et al. Revista Eletrônica Acervo Médico. Revista Eletronica Acervo Saude. 2022.
New publications
Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.
In vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesis
Hess S, Kendall TJ, Pena M, et al. Cell Reports Medicine. Elsevier BV. 2022; 3 (11) : 100820.
Summary report on the twentieth meeting of the Regional Programme Review Group and national neglected tropical diseases programme managers, virtual meeting, 23–25 May 2022
WHO Regional Office for the Eastern Mediterranean. World Health Organization. 2022.
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis
Ezenduka CC, Namadi A, Tahir D, et al. Cost Effectiveness and Resource Allocation. Springer Science and Business Media LLC. 2022.
Access to Public Healthcare Rehabilitation Services by Persons with Disabilities in South Africa: a Scoping Review
Van Biljon HM, Salie B, Van Wyk JC, et al. Disability, CBR & Inclusive Development. Stichting Liliane Fonds. 2022; 33 (3) : 41.
Pushing Down the Walls: Advocating for "Rehabilitation for All" in South Africa
Cobbing S, Gaede B, Chetty V, et al. Disability, CBR & Inclusive Development. Stichting Liliane Fonds. 2022; 33 (3) : 68.
Epidemiological scenario of leprosy in marginalized communities of India: Focus on scheduled tribes
Singh P, Sharma M. Indian Journal of Medical Research. Medknow. 2022.
Risk areas for the occurrence of leprosy in border countries of South America - Brazil and Argentina
Silva-Sobrinho RA, Oliveira KS, Deschutter EJ, et al. PLOS ONE. Public Library of Science (PLoS). 2022; 17 (11) : e0276977.
Recording of leprosy cases in India: Need for a user-friendly and effective app
Rao P, Bahunuthula R, Varala S, et al. Indian Dermatology Online Journal. Medknow. 2022; 13 (6) : 697.
Opportunity of Leprosy Information Systems as An Effort to Eliminate Leprosy in Papua: Systematic Review
Bahari , Sutantri , Huriah T. Jurnal Aisyah: Jurnal Ilmu Kesehatan. 2022; 7 (S2) : 31-38.
Seroepidemiologic survey of the household contacts of leprosy patients.
Barbosa A, da Silva S, Toledo A, et al. Revista da Associacao Medica Brasileira (1992). 2022; 68 (10) : 1389-1393.
Leprosy chemoprophylaxis of household contacts: A survey of Canadian infectious disease and tropical medicine specialists.
Boodman C, Keystone J, Bogoch I. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2022; 7 (1) : 8-13.
The impact of climate change related extreme weather events on people with pre-existing disabilities and chronic conditions: a scoping review
Lindsay S, Hsu S, Ragunathan S, et al. Disability and Rehabilitation. Informa UK Limited. 2022.
Global investments to optimise the health and wellbeing of children with disabilities: a call to action
Olusanya BO, Davis AC, Hadders-Algra M, et al. The Lancet. Elsevier BV. 2022.
Self-Care Program for Patients with Leprosy Grade 2 in Abu Zaabal Leprosy Colony
Melika FF, Hassan MM, Abd-Elkader W. Egyptian Journal of Nursing and Health Sciences. 2022; 3 (2) : 22-45.
The Influence Of Perceived Benefits And Commitment On Selfcare Agency Of People With Leprosy In Preventing The Transmission Of Leprosy In Sumenep, Madura, Indonesia
Hannan M, Notobroto HB, Hidayat S. Journal of Pharmaceutical Negative Results. 2022.
Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States
Franco-Paredes C, Garcia-Creighton E, Henao-Martínez A, et al. Therapeutic Advances in Infectious Disease. SAGE Publications. 2022.
Lucio phenomenon with concomitant necrotizing fasciitis and acute kidney injury.
Norman T, Zikry J, Worswick S, et al. Dermatology online journal. 2022.
A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.
Muddebihal A, Sardana K, Khurana A, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022.
The protective role of tissue-resident interleukin 17A-producing gamma delta T cells in Mycobacterium leprae infection.
Liu Y, Shi C, Ma S, et al. Frontiers in immunology. 2022.
Genetic polymorphisms of toll-like receptors in leprosy patients from southern Brazil.
Masin P, Visentin H, Elpidio L, et al. Frontiers in genetics. 2022.
Pathogenicity and virulence of Mycobacterium leprae
Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Virulence. 2022; 13 (1) : 1985-2011.
Editorial: Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention
Pinheiro RO, Rosa PS, Spencer JS, et al. Frontiers in Medicine. Frontiers Media SA. 2022.
A-waves associated are with neuropathic pain in leprosy.
Garbino J, Kirchner D, França M. Muscle & nerve. 2022.
Magnitude dos episódios reacionais na hanseníase em serviço ambulatorial especializado
Chaves AFCP, de Araújo OD, Sousa EC, et al. Hansen Int. 2022.
Lepromatous leprosy with central serous chorioretinopathy
Goel S, Gogia K, Singla R, et al. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2022.
Leprosy rash precipitated by immunotherapy for suspected inflammatory neuropathy.
Leung A, Arnold B, Hodgson T, et al. Practical neurology. 2022.
Should we persist with the term Lazarine leprosy? A historical perspective
Asokan N, Valsalan V. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2022.
News & Events
Calls for proposals - Leprosy Research Initiative
This year, LRI has announced two calls for proposals! This includes the regular annual call for proposals, for funding commencing in 2024. LRI funds research with a focus on leprosy – including research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases that share cross-cutting issues with leprosy. Alongside the regular call, LRI has now introduced a new Research capacity strengthening grant, for funding commencing in 2023. Letters of Intent can now be submitted via the LRI application portal. The deadline for submission for both calls is January 27th, 2023. Interested? More information can be found on their website!
Webinar: Global Health Equity Dialogue Series
13 December, 2022
How Can Health Equity Accelerate Progress toward Universal Health Coverage? Join RTI International for the first virtual session in a Global Health Equity Dialogue Series that will serve as a platform for exchange on how the international community can address the major drivers of health inequities to achieve health for all.
Webinar: Three Years of Global Health Compassion Rounds in Synthesis
20 December, 2022
The Global Health Compassion Rounds has brought together public health professionals from around the world to explore the overlap between their work, their lives, and compassion. This GHCR will explore what has been shared, highlighting cross-cutting themes, and creating directions for the future.
The 5th Asia-Pacific Community-Based Inclusive Development Congress
15-17 March, 2023
The 5th AP-CBID Congress will take place in Phnom Penh, Cambodia. The content of the congress focuses on strengthening social and economic empowerment of persons with disabilities during and after the COVID-19 pandemic through community-based inclusive development.
Call for Grant Proposals - Sasakawa Leprosy Initiative
Through its grant program, Sasakawa supports projects that contribute to building a society in which persons affected by leprosy have access to the treatment and services they need and can live their lives free from stigma and discrimination.
Lancet Series Launch: Racism, discrimination and health.
9 December, 2022
Race & Health is excited to announce a new Lancet Series on racism, xenophobia, discrimination and the determination of health. Join the launch, in-person or virtually, to discuss the pervasive nature of racism, xenophobia, and discrimination on health inequities globally, and what we can do to improve the lives of minoritised people.
2nd International Conference on Public Health in Africa
13-15 December, 2022
The 2nd International Conference on Public Health in Africa will be held in Kigali, Rwanda, and provides an unique platform for African researchers, policymakers and stakeholders to come together and share perspectives and research findings in public health.
Webinar: Make way for people with disabilities in SRHR
20 December, 2022
How do you ensure equal access to your Sexual and Reproductive Health and Rights programmes for people with disabilities? Share-Net Netherlands, Liliane Foundation, and the Dutch Coalition on Disability and Development (DCDD) are organizing a webinar on SHRH and disability inclusion. DCDD's newest quick guide will be launched, which offers a wide range of practical tips and tools to ensure inclusion throughout the programme cycle.
Links
Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
ALLF - Official website of the Association des Léprologues de Langue Française
LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)
WHO Goodwill Ambassador's Leprosy Bulletin
Leprosy Review Repository (1928-2001)
Fontilles Revista de Leprología
GDPR & the Infolep newsletter
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.
Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.
Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.
You can update your preferences or unsubscribe from this list at any time.
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/fa030498-95d0-4358-8372-6458c2885a1dn%40googlegroups.com.
No comments:
Post a Comment